These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32848038)

  • 1. Laboratory-Based Surveillance of Clostridium difficile Infection in Australian Health Care and Community Settings, 2013 to 2018.
    Hong S; Putsathit P; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Clostridioides difficile isolates recovered from two Phase 3 surotomycin treatment trials by restriction endonuclease analysis, PCR ribotyping and antimicrobial susceptibilities.
    Cheknis A; Devaris D; Chesnel L; Dale SE; Nary J; Sambol SP; Citron DM; Goering RV; Johnson S
    J Antimicrob Chemother; 2020 Nov; 75(11):3120-3125. PubMed ID: 32747931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the phylogenetics and resistome of the major
    O'Grady K; Hong S; Putsathit P; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; McGlinchey A; Levy A; Moore CV; Nimmo G; Prendergast L; Robson J; Speers DJ; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR
    Microb Genom; 2024 May; 10(5):. PubMed ID: 38717815
    [No Abstract]   [Full Text] [Related]  

  • 4. Laboratory-based surveillance of Clostridium difficile circulating in Australia, September - November 2010.
    Cheng AC; Collins DA; Elliott B; Ferguson JK; Paterson DL; Thean S; Riley TV
    Pathology; 2016 Apr; 48(3):257-60. PubMed ID: 27020502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology of endemic Clostridioides difficile infection in Japan.
    Senoh M; Kato H
    Anaerobe; 2022 Apr; 74():102510. PubMed ID: 34990814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridioides (Clostridium) difficile isolated from paediatric patients in Western Australia 2019-2020.
    Perumalsamy S; Lim SC; Riley TV
    Pathology; 2022 Jun; 54(4):460-465. PubMed ID: 35125203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial Susceptibilities of Clostridium difficile Isolates from 12 Asia-Pacific Countries in 2014 and 2015.
    Lew T; Putsathit P; Sohn KM; Wu Y; Ouchi K; Ishii Y; Tateda K; Riley TV; Collins DA
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32393487
    [No Abstract]   [Full Text] [Related]  

  • 8. A nationwide study of molecular epidemiology and antimicrobial susceptibility of Clostridioides difficile in South Korea.
    Byun JH; Kim H; Kim JL; Kim D; Jeong SH; Shin JH; Kim YA; Shin JH; Shin KS; Uh Y
    Anaerobe; 2019 Dec; 60():102106. PubMed ID: 31655214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14.
    Knight DR; Giglio S; Huntington PG; Korman TM; Kotsanas D; Moore CV; Paterson DL; Prendergast L; Huber CA; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV
    J Antimicrob Chemother; 2015 Nov; 70(11):2992-9. PubMed ID: 26221017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A series of three cases of severe Clostridium difficile infection in Australia associated with a binary toxin producing clade 2 ribotype 251 strain.
    Wehrhahn MC; Keighley C; Kurtovic J; Knight DR; Hong S; Hutton ML; Lyras D; Wang Q; Leong R; Borody T; Edye M; Riley TV
    Anaerobe; 2019 Feb; 55():117-123. PubMed ID: 30500477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of a Clostridioides difficile sentinel surveillance system in Germany: First insights for 2019-2021.
    Abdrabou AMM; Bischoff M; Mellmann A; von Müller L; Margardt L; Gärtner BC; Berger FK;
    Anaerobe; 2022 Oct; 77():102548. PubMed ID: 35307546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic characterisation of Clostridium difficile PCR ribotype 251, an emerging multi-locus sequence type clade 2 strain in Australia.
    Hong S; Knight DR; Chang B; Carman RJ; Riley TV
    Anaerobe; 2019 Dec; 60():102066. PubMed ID: 31260740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolutionary and Genomic Insights into
    Knight DR; Kullin B; Androga GO; Barbut F; Eckert C; Johnson S; Spigaglia P; Tateda K; Tsai PJ; Riley TV
    mBio; 2019 Apr; 10(2):. PubMed ID: 30992351
    [No Abstract]   [Full Text] [Related]  

  • 14. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013.
    Pituch H; Obuch-Woszczatyński P; Lachowicz D; Wultańska D; Karpiński P; Młynarczyk G; van Dorp SM; Kuijper EJ;
    Euro Surveill; 2015; 20(38):. PubMed ID: 26536049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biogeographic distribution and molecular epidemiology of
    Cautivo-Reyes K; Knight DR; Bowie D; Moreira-Grez B; Whiteley AS; Riley TV
    Appl Environ Microbiol; 2023 Oct; 89(10):e0037923. PubMed ID: 37823643
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18.
    Putsathit P; Hong S; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; McGlinchey A; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR
    J Antimicrob Chemother; 2021 Jun; 76(7):1815-1821. PubMed ID: 33895826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Healthcare-Associated and Community-Associated Clostridioides difficile Infections among Adults, Canada, 2015-2019.
    Du T; Choi KB; Silva A; Golding GR; Pelude L; Hizon R; Al-Rawahi GN; Brooks J; Chow B; Collet JC; Comeau JL; Davis I; Evans GA; Frenette C; Han G; Johnstone J; Kibsey P; Katz KC; Langley JM; Lee BE; Longtin Y; Mertz D; Minion J; Science M; Srigley JA; Stagg P; Suh KN; Thampi N; Wong A; Hota SS
    Emerg Infect Dis; 2022 Jun; 28(6):1128-1136. PubMed ID: 35470794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Prevalence of Clostridium difficile in Home Gardens in Western Australia.
    Shivaperumal N; Chang BJ; Riley TV
    Appl Environ Microbiol; 2020 Dec; 87(1):. PubMed ID: 33097511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon.
    Berger FK; Rasheed SS; Araj GF; Mahfouz R; Rimmani HH; Karaoui WR; Sharara AI; Dbaibo G; Becker SL; von Müller L; Bischoff M; Matar GM; Gärtner B
    Int J Med Microbiol; 2018 Apr; 308(3):358-363. PubMed ID: 29478838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.
    Furuya-Kanamori L; Riley TV; Paterson DL; Foster NF; Huber CA; Hong S; Harris-Brown T; Robson J; Clements AC
    J Clin Microbiol; 2017 Jan; 55(1):216-225. PubMed ID: 27807147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.